COMMUNIQUÉS West-GlobeNewswire

Corvus Pharmaceuticals Announces Appointment of New Member of Board of Directors and Hiring of Chief Medical Officer
28/01/2019
BURLINGAME, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
28/01/2019
RUTHERFORD, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]
Nextech’s EDGE 2019 Creates Hub for Collaboration and Education for Medical Specialty Professionals
28/01/2019
The fifth annual user conference will offer insights into upcoming industry trends and provide education and networking opportunities for healthcare providers in all roles TAMPA, Fla., Jan. 28, 2019 (GLOBE NEWSWIRE) -- [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2018
28/01/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les sociétés dont [...]
Indiana Biosciences Research Institute collaboration helps discover new genetic disease
28/01/2019
INDIANAPOLIS, Jan. 28, 2019 (GLOBE NEWSWIRE) -- A collaborative research project led in part by the Indiana Biosciences Research Institute (IBRI) has resulted in the first description of a new monogenic disease, named [...]
Dr. Alice Gottlieb to Present Hidradenitis Suppurativa Findings at American Academy of Dermatology Annual Meeting
28/01/2019
AUSTIN, Texas, Jan. 28, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today that Dr. Alice Gottlieb, M.D., Ph.D., will be giving the presentation “Bermekimab Shows Efficacy for Treating Hidradenitis [...]
North American Partners in Anesthesia (NAPA) quality data analysis suggests a surprising correlation between labor pain expectations in “millennial moms,” patient satisfaction and value-based payments
28/01/2019
A White Paper by Brent Lee, MD, MPH, Director of Clinical Excellence and Performance Improvement for North American Partners in Anesthesia (NAPA), describes the implications of a statistical study for hospital loyalty [...]
Ossur Hf : Transactions in relation to share buyback program
28/01/2019
Announcement no. 05/2019 28 January 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Vystar Debuts Enhanced RxAir® UV Light Air Purifiers to Fight Flu, Colds & Airborne Germs
28/01/2019
Features longer-lasting, more effective UV light for more efficient inactivation of viruses and bacteria RxAir available for medical, business and residential RxAir now available via Vystar’s medical distributors [...]
TOMI Environmental Solutions, Inc. Enters Into Exclusive Co-Marketing and Supply Agreement With Arkema Inc. to Develop the Market for Fogging Technology in Food Safety
28/01/2019
BEVERLY HILLS, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQX: TOMZ) , a global company that specializes in disinfection and decontamination essentials using its premier [...]
Portola Pharmaceuticals Appoints Sheldon Koenig as Chief Commercial Officer
28/01/2019
Brings to Portola 30 Years’ Commercial Experience and Key Therapeutic Area Launch Expertise SOUTH SAN FRANCISCO, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced [...]
Protech Home Medical Announces Record 11X Adjusted EBITDA Growth and Significant Operating Cash Flow Growth in Year End Audited Financials
28/01/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Protech Home [...]
Dr. Mitesh Borad Joins OncBioMune Scientific Advisory Board
28/01/2019
BATON ROUGE, La., Jan. 28, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Cannabix Technologies Completes Breath Collection Unit and Provides Update
28/01/2019
The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety VANCOUVER, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies [...]
Golden Leaf Holdings Announces Appointment of Larry H. Martin to Board of Directors
28/01/2019
PORTLAND, Ore., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
BIOLIFE4D Appoints Management Advisory Board
28/01/2019
Company names Dr. Michael Davidson, Mr. Stephen Simes, Dr. Mark Weinberg, and Mr. Bruce Werner as strategic advisors CHICAGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue [...]
Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients
28/01/2019
Actigraphy is Being Utilized to Evaluate Multiple Clinically Meaningful Activity Parameters in the Ongoing INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary Hypertension Associated with Interstitial Lung [...]
New Clinical Trial Finds Milestone Scientific’s CompuFlo® Instrument a Safe Alternative to Current Standards of Care
28/01/2019
Publication in top ranked Anesthesia & Analgesia Journal compares CompuFlo pressure sensing to fluoroscopy and loss of resistance LIVINGSTON, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: [...]
Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy
28/01/2019
Allogene to Initiate the ALPHA Study for ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma ALLO-647, Allogene’s Proprietary anti-CD52 Antibody, Will be Administered as Part of the Lymphodepletion Regimen SOUTH SAN [...]

Pages